Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b Study of Baricitinib in RA on Background Methotrexate (JADA)
NCT01185353Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2010
- Primary completion
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Antibody-Based Therapeutics
- Countries
- 9
01
Overview
A Phase 2 trial of baricitinib in rheumatoid arthritis (RA), sponsored by Eli Lilly and Company. Started Oct 2010; status: completed.
02
Drugs
baricitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01185353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01185353.